Zai Lab (ZLAB) Times Interest Earned (2018 - 2026)
Zai Lab (ZLAB) posted Times Interest Earned of -$42.39 for Q1 2026, down 1200.16% sequentially from -$3.26 in Q4 2025, and up 10.65% YoY from -$38.3 in Q1 2025.
Zai Lab (ZLAB) Times Interest Earned (2018 - 2026) Analysis & Trends
Zai Lab has reported Times Interest Earned for 9 years, with the latest figure at -$42.39 in Q1 2026.
- Quarterly Times Interest Earned rose 10.65% year-over-year to -$42.39 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.48 (up 87.6% YoY) and the FY2025 annual result came in at -$0.53, up 25.19% from the prior year.
- Times Interest Earned retreated to -$42.39 in Q1 2026 per ZLAB's latest filing, from -$3.26 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.34 in Q4 2022 and troughed at -$622.2 in Q1 2024.
- A 5-year average of -$101.41 and a median of -$43.5 in 2025 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2023 and 2025: Times Interest Earned slumped 3785.31% in 2023, then surged 94.79% in 2025.
- Over 5 years, Times Interest Earned stood at -$0.34 in 2022, then plunged by 3785.31% to -$13.31 in 2023, then sank by 370.22% to -$62.57 in 2024, then soared by 94.79% to -$3.26 in 2025, then plunged by 1200.16% to -$42.39 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$42.39, -$3.26, and -$34.87 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | -48.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -48.20 |
| Mar 31, 2026 | -42.39 |
| Dec 31, 2025 | -3.26 |
| Sep 30, 2025 | -34.87 |
| Jun 30, 2025 | -43.50 |
| Mar 31, 2025 | -47.44 |
| Dec 31, 2024 | -62.57 |
| Sep 30, 2024 | -91.08 |
| Jun 30, 2024 | -154.60 |
| Mar 31, 2024 | -622.20 |
| Dec 31, 2023 | -13.31 |
| Dec 31, 2022 | -0.34 |
| Dec 31, 2021 | -1.16 |
| Dec 31, 2020 | -3,969.00 |
| Sep 30, 2020 | -1,773.42 |
| Jun 30, 2020 | -0.13 |
| Mar 31, 2020 | -691.37 |
| Dec 31, 2019 | -20.30 |
| Sep 30, 2019 | -853.26 |
| Dec 31, 2018 | -47.11 |